Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I.
Levine
R A
RA
Sobel
B E
BE
D020909:Acarbose / Q000627:therapeutic use; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007340:Insulinoma / Q000150:complications* / Q000503:physiopathology / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000503:physiopathology; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D013844:Thiazoles / Q000627:therapeutic use
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D017395:Plasminogen Activator Inhibitor 1; D013844:Thiazoles; D020909:Acarbose